2023 Emerging Leader Award Kanecia Zimmerman, MD’07, HS’07-’11, 12-’15, PhD, MPH
Kanecia Zimmerman, MD’07, HS’07-’11, 12-’15, PhD, MPH, is an associate professor of pediatrics in the Division of Critical Care Medicine in the Department of Pediatrics at Duke University School of Medicine.
2023 Emerging Leader Award Kevin O. Saunders, PhD’10
Kevin O. Saunders, PhD’10, is an associate professor in surgery, molecular genetics and microbiology, and in immunology. He is the faculty chairperson for the Diversity, Equity & Inclusion Committee and associate director of the Duke Human Vaccine Institute (DHVI).
2023 Distinguished Faculty Award E. Shelley Hwang, MD, MPH
Shelley Hwang, MD, MPH, is the Mary and Deryl Hart Professor of Surgery, vice chair of research of surgery, professor of radiology, and disease group leader of the Breast Cancer Program at the Duke Cancer Institute.
2023 Transformational Leadership Award LATIN-19 Executive Team
A diverse team of Duke faculty and community advocates created LATIN-19 (Latinx Advocacy Team and Interdisciplinary Network for COVID-19) in March 2020 to advocate for and bring awareness to the needs of the Latinx community in North Carolina during the COVID-19 crisis.
Doctor of Physical Therapy Class of 2024 White Coat Ceremony
The Class of 2024 White Coat Ceremony marked a milestone for the students who have finished the didactic portion of the program and set out to begin a year of clinical experiences before graduating next May.
Pharmaceutical Quality vs. Affordability
MD/PhD student Christopher Behrer's research examines how to regulate pharmaceutical quality.
Congratulations! SOM Faculty accepted into ELAM and ELH
Three faculty selected as members of the 2023-2024 class of fellows for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program and the parallel Executive Leadership in Health Care Program.
Dean Klotman's Friday Message & Conversation with Eleanora Lad, MD, PhD
A Conversation with Eleanora Lad, MD, PhD, associate professor of ophthalmology, about the recent clinical trials that led to the first drug approved the FDA to treat a devastating eye disease called Geographic Atrophy.
Dean’s Staff Award Winners Named
Four staff members from across the School of Medicine have been named recipients of the inaugural Dean’s Staff Awards.
Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination
A drug combination that shows little overall survival benefit in white men with advanced prostate cancer has a far greater effect in Black men with the disease, according to interim results from a study led by the Duke Cancer Institute.